Bone Volume Changes After Socket Preservation Using Geistlich Bio-Oss Collagen and Mucograft Seal

计划入组 30 人 · 首次发布于 2018 年 1 月 10 日

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

计划入组 30 人 · 首次发布于 2024 年 7 月 8 日

Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects

计划入组 25 人 · 首次发布于 2014 年 12 月 8 日

Ebio-1

RBIO-1

EGFRvIII (iBio)

KBIO INC.

United States

NOBIO LTD

Israel

OHIO UNIVERSITY

United States

Mount Sinai's Dr. Vivek Reddy to Lead Orchestra BioMed's BACKBEAT Study as Executive Chairman

Orchestra BioMed's BACKBEAT Trial Launch Drives 40% Stock Surge Amid Promising Cardiovascular Pipeline

Bayer Launches Centafore: New Imaging Core Lab to Enhance Clinical Trial Imaging and SaMD Development